Takeda, Merck KGaA Sign Aptamer Development Deals With Archemix
Archemix gets $6 million up-front in Takeda deal; Merck agrees to make $29.8 million equity investment in Cambridge, Mass. company.
Archemix gets $6 million up-front in Takeda deal; Merck agrees to make $29.8 million equity investment in Cambridge, Mass. company.